login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
MONOPAR THERAPEUTICS INC (MNPR) Stock News
NASDAQ:MNPR - Nasdaq -
US61023L2079
-
Common Stock
- Currency: USD
34.65
-5.45 (-13.59%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
MNPR Latest News, Press Relases and Analysis
All
Press Releases
2 months ago - By: Benzinga
- Mentions:
CHH
HST
HLT
SEPN
This Hilton Worldwide Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
2 months ago - By: Monopar Therapeutics Inc.
Monopar and EDNOC Announce Expanded Access Program for MNPR-101-Zr and MNPR-101-Lu in Advanced Cancers
2 months ago - By: Monopar Therapeutics Inc.
Monopar and EDNOC Announce Expanded Access Program for MNPR-101-Zr and MNPR-101-Lu in Advanced Cancers
2 months ago - By: Monopar Therapeutics Inc.
Monopar Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes
10 months ago - By: Benzinga
What's Going On With Monopar Therapeutics Shares Friday?
3 months ago - By: Monopar Therapeutics Inc.
Monopar Therapeutics Reports First Quarter 2025 Financial Results and Recent Developments
3 months ago - By: Monopar Therapeutics Inc.
Monopar Therapeutics Reports First Quarter 2025 Financial Results and Recent Developments
3 months ago - By: Monopar Therapeutics Inc.
Monopar Presents ALXN1840 Late-Breaker Data at EASL 2025
3 months ago - By: Monopar Therapeutics Inc.
Monopar Presents ALXN1840 Late-Breaker Data at EASL 2025
3 months ago - By: Yahoo Finance
- Mentions:
NUTX
CMRX
FITB
MASS
...
Why Nutex Health Inc. (NUTX) is Surging in 2025
3 months ago - By: Yahoo Finance
- Mentions:
AGL
CMRX
SYY
FITB
...
Why agilon health, inc. (AGL) is Surging in 2025
3 months ago - By: Yahoo Finance
- Mentions:
TLSA
PHH
ATPC
AGL
...
Why Tiziana Life Sciences Ltd (TLSA) is Surging in 2025
3 months ago - By: Yahoo Finance
- Mentions:
PVLA
TIGO
SYY
AGL
...
Why Monopar Therapeutics Inc. (MNPR) is Surging in 2025
3 months ago - By: Yahoo Finance
- Mentions:
DERM
NVCT
CMRX
MASS
Why Journey Medical Corporation (DERM) is Surging in 2025
3 months ago - By: Monopar Therapeutics Inc.
Monopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025
3 months ago - By: Monopar Therapeutics Inc.
Monopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025
4 months ago - By: Monopar Therapeutics Inc.
Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments
4 months ago - By: Monopar Therapeutics Inc.
Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments
8 months ago - By: Monopar Therapeutics Inc.
Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants
8 months ago - By: Monopar Therapeutics Inc.
Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants
8 months ago - By: Monopar Therapeutics Inc.
Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu
8 months ago - By: Monopar Therapeutics Inc.
Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu
8 months ago - By: Monopar Therapeutics Inc.
Monopar to Present at the 36th Annual Piper Sandler Healthcare Conference
8 months ago - By: Monopar Therapeutics Inc.
Monopar to Present at the 36th Annual Piper Sandler Healthcare Conference
8 months ago - By: MarketBeat
- Mentions:
SEZL
MSTR
AZN
3 Momentum Stocks Soaring Into 2025 and Beyond
9 months ago - By: Monopar Therapeutics Inc.
Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments
9 months ago - By: Monopar Therapeutics Inc.
Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments
9 months ago - By: Monopar Therapeutics Inc.
Monopar Therapeutics Inc. Announces Closing of $19.2 Million Public Offering of Common Stock
10 months ago - By: Monopar Therapeutics Inc.
Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock
10 months ago - By: Monopar Therapeutics Inc.
Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock
10 months ago - By: Monopar Therapeutics Inc.
Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock
10 months ago - By: Monopar Therapeutics Inc.
Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock
Please enable JavaScript to continue using this application.